Femasys' (FEMY) "Buy" Rating Reiterated at HC Wainwright : v

HC Wainwright reiterated their buy rating on shares of Femasys (NASDAQ:FEMY – Free Report) in a research report released on Thursday, Benzinga reports. HC Wainwright currently has a $5.00 price objective on the stock. Femasys Price Performance NASDAQ:FEMY opened at $0.43 on Thursday. The firm has a market cap of $6.48 million, a P/E ratio […]

Related Keywords

Canada , United States , Hong Kong , Japan , , Femasys Company Profile , Vanguard Group Inc , Clear Creek Financial Management , Cetera Advisor Networks , Nasdaq , Virtu Financial , Femasys Inc , Free Report , Get Free Report , Advisor Networks , Creek Financial Management , Femasys Daily , Femasys , Nasdaq Femy , Femy , Medical , Reiterated Rating , Hc Wainwright ,